Dec 4, 2003 (CIDRAP News) Thousands of US Customs and Border Protection (CBP) officers will help the Food and Drug Administration (FDA) inspect imported food under an agreement signed yesterday, according to the FDA.
(CIDRAP News) In a flurry of pre-adjournment activity yesterday, Congress appropriated about $2.5 billion for bioterrorism preparedness, including $1 billion for state and local efforts, according to an aide to Sen. Bill Frist, R-Tenn.
(CIDRAP News) The Food and Drug Administration (FDA) has completed a new inspection of BioPort Corp., the only US manufacturer of the anthrax vaccine, and a company official is predicting approval of the facility after a few remaining concerns are ironed out.
(CIDRAP News) The US Department of Agriculture (USDA) will continue to test meat for Salmonella to confirm that meat processors' food safety systems are adequate, despite a court ruling that Salmonella tests can't be used to shut down a plant, Agriculture Secretary Ann M. Veneman announced this week.
(CIDRAP News) Because of a small theoretical risk that anthrax spores can hide in the lungs for up to 100 days and grow after antibiotic treatment is stopped, the anthrax vaccine and an extension of antibiotic treatment will be offered to people who may have been exposed in the recent anthrax attacks, federal health officials announced yesterday afternoon.
(CIDRAP News) If bioterrorists released smallpox virus today, each person who contracted the disease could infect as many as 10 to 12 more before health authorities would recognize the disease and act to contain it, according to experts writing in the Dec 13 issue of Nature.
(CIDRAP News) A federal appeals court has ruled that the US Department of Agriculture's (USDA's) Salmonella performance standard for meat packers is illegal, depriving USDA of authority to shut down packing plants for producing meat with Salmonella levels exceeding the standard.
(CIDRAP News) The US House of Representatives on Wednesday overwhelmingly approved a bill authorizing about $2.9 billion in spending on preparedness for bioterrorism and other public health emergencies.
(CIDRAP News) The Centers for Disease Control and Prevention's (CDC's) priorities for research on anthrax include development of an antitoxin, aerosolization of anthrax powders sent by mail, and postexposure prophylaxis, CDC officials said this week.